Geron (US) and Dianon Systems (US) co-operate on telomerase project:
This article was originally published in Clinica
Geron (US) and Dianon Systems (US) have agreed to co-operate on the development of telomerase-based cancer diagnostics. The so-called immortalising enzyme is found in malignant cells but is inactive in normal tissue. The agreement allows both companies to conduct further development and commercialisation with other partners in the future. Geron is also developing telomerase inhibitors for cancer treatment.